F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Non-alcoholic steatohepatitis

Page 1 of 3 ( 117 items )
<<
1
2
3
>>

1	Non-invasively differentiate non-alcoholic steatohepatitis by visualizing hepatic integrin αvβ3 expression with a targeted molecular imaging modality 11/6/2024 9:51:01 AM \| Browse: 58 \| Download: 270
2	Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk 8/2/2023 9:29:03 AM \| Browse: 240 \| Download: 841
3	Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver 9/23/2022 10:13:16 AM \| Browse: 441 \| Download: 1098
4	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 459 \| Download: 840
5	Therapies for non-alcoholic fatty liver disease: A 2022 update 9/23/2022 12:48:56 AM \| Browse: 466 \| Download: 1058
6	Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis 9/15/2022 1:37:25 PM \| Browse: 417 \| Download: 891
7	Transcriptome changes in stages of non-alcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 511 \| Download: 920
8	Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis 7/27/2022 1:17:37 PM \| Browse: 440 \| Download: 857
9	Minireview: Mechanisms of ductular reaction in non-alcoholic steatohepatitis 5/17/2022 12:57:55 PM \| Browse: 482 \| Download: 824
10	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 560 \| Download: 913
11	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 532 \| Download: 1173
12	Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis 4/22/2022 10:52:23 AM \| Browse: 569 \| Download: 1783
13	Is there a role of lipid-lowering therapies in the management of fatty liver disease? 1/21/2022 8:16:14 AM \| Browse: 437 \| Download: 860
14	Abnormal liver enzymes: A review for clinicians 11/24/2021 9:54:22 AM \| Browse: 533 \| Download: 833
15	Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study 11/19/2021 11:15:33 AM \| Browse: 616 \| Download: 1357
16	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 458 \| Download: 802
17	Hepatocellular carcinoma in non-alcoholic fatty liver disease: A growing challenge 9/22/2021 8:09:41 AM \| Browse: 610 \| Download: 1079
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 680 \| Download: 1020
19	Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease 5/20/2021 3:14:20 PM \| Browse: 595 \| Download: 1403
20	Non-alcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration 4/28/2021 12:31:49 PM \| Browse: 786 \| Download: 1209
21	Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population 3/12/2021 9:59:35 AM \| Browse: 815 \| Download: 1477
22	Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? 2/25/2021 3:45:30 PM \| Browse: 702 \| Download: 1613
23	Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort 2/20/2021 2:51:13 AM \| Browse: 638 \| Download: 1571
24	Experimental models of metabolic and alcoholic fatty liver disease 12/30/2020 1:59:10 PM \| Browse: 821 \| Download: 1402
25	Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic-Chinese population 12/18/2020 5:58:43 AM \| Browse: 733 \| Download: 1698
26	Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! 10/24/2020 2:27:20 AM \| Browse: 903 \| Download: 1413
27	Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy 9/21/2020 4:02:08 PM \| Browse: 708 \| Download: 1619
28	Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice 9/4/2020 7:25:49 AM \| Browse: 757 \| Download: 2154
29	Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis 8/25/2020 9:16:00 AM \| Browse: 743 \| Download: 1765
30	Lipidomics in non-alcoholic fatty liver disease 8/25/2020 9:16:00 AM \| Browse: 796 \| Download: 1296
31	Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study 7/23/2020 5:00:01 AM \| Browse: 837 \| Download: 1821
32	Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis 7/23/2020 5:00:01 AM \| Browse: 1029 \| Download: 2257
33	Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease 7/7/2020 2:50:53 PM \| Browse: 874 \| Download: 1508
34	Association between non-alcoholic fatty liver disease and obstructive sleep apnea 5/28/2020 1:08:01 PM \| Browse: 924 \| Download: 1561
35	Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease 5/7/2020 5:03:30 AM \| Browse: 1235 \| Download: 1857
36	Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review 4/21/2020 6:56:33 AM \| Browse: 857 \| Download: 1377
37	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 961 \| Download: 1532
38	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 1062 \| Download: 2198
39	Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? 8/14/2019 1:31:33 PM \| Browse: 912 \| Download: 1542
40	Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? 8/7/2019 7:09:17 AM \| Browse: 1054 \| Download: 1848
41	Importance of fatigue and its measurement in chronic liver disease 7/28/2019 10:51:57 AM \| Browse: 1128 \| Download: 1761
42	Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease 7/26/2019 11:08:19 AM \| Browse: 889 \| Download: 1372
43	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1266 \| Download: 2134
44	Microbial metabolites in non-alcoholic fatty liver disease 5/6/2019 2:06:54 AM \| Browse: 914 \| Download: 1952
45	Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis 4/26/2019 3:40:00 AM \| Browse: 1077 \| Download: 2211
46	Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis 3/7/2019 3:51:24 AM \| Browse: 1299 \| Download: 2155
47	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1197 \| Download: 1715
48	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1359 \| Download: 1812
49	Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology 12/27/2018 9:28:07 AM \| Browse: 943 \| Download: 1484
50	Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 11/21/2018 4:08:59 AM \| Browse: 1006 \| Download: 1306

Page 1 of 3 ( 117 items )
<<
1
2
3
>>

1	Non-invasively differentiate non-alcoholic steatohepatitis by visualizing hepatic integrin αvβ3 expression with a targeted molecular imaging modality 11/6/2024 9:51:01 AM \| Browse: 58 \| Download: 270
2	Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk 8/2/2023 9:29:03 AM \| Browse: 240 \| Download: 841
3	Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver 9/23/2022 10:13:16 AM \| Browse: 441 \| Download: 1098
4	Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future? 9/23/2022 12:48:56 AM \| Browse: 459 \| Download: 840
5	Therapies for non-alcoholic fatty liver disease: A 2022 update 9/23/2022 12:48:56 AM \| Browse: 466 \| Download: 1058
6	Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis 9/15/2022 1:37:25 PM \| Browse: 417 \| Download: 891
7	Transcriptome changes in stages of non-alcoholic fatty liver disease 7/27/2022 1:17:37 PM \| Browse: 511 \| Download: 920
8	Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis 7/27/2022 1:17:37 PM \| Browse: 440 \| Download: 857
9	Minireview: Mechanisms of ductular reaction in non-alcoholic steatohepatitis 5/17/2022 12:57:55 PM \| Browse: 482 \| Download: 824
10	Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis 4/29/2022 11:12:04 AM \| Browse: 560 \| Download: 913
11	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 532 \| Download: 1173
12	Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis 4/22/2022 10:52:23 AM \| Browse: 569 \| Download: 1783
13	Is there a role of lipid-lowering therapies in the management of fatty liver disease? 1/21/2022 8:16:14 AM \| Browse: 437 \| Download: 860
14	Abnormal liver enzymes: A review for clinicians 11/24/2021 9:54:22 AM \| Browse: 533 \| Download: 833
15	Immunoglobulin G in non-alcoholic steatohepatitis predicts clinical outcome: A prospective multi-centre cohort study 11/19/2021 11:15:33 AM \| Browse: 616 \| Download: 1357
16	Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit? 10/20/2021 7:18:39 AM \| Browse: 458 \| Download: 802
17	Hepatocellular carcinoma in non-alcoholic fatty liver disease: A growing challenge 9/22/2021 8:09:41 AM \| Browse: 610 \| Download: 1079
18	Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist? 9/7/2021 8:15:21 AM \| Browse: 680 \| Download: 1020
19	Combination of type IV collagen 7S, albumin concentrations, and platelet count predicts prognosis of non-alcoholic fatty liver disease 5/20/2021 3:14:20 PM \| Browse: 595 \| Download: 1403
20	Non-alcoholic fatty liver disease and cardiovascular concerns: The time for hepatologist and cardiologist close collaboration 4/28/2021 12:31:49 PM \| Browse: 786 \| Download: 1209
21	Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population 3/12/2021 9:59:35 AM \| Browse: 815 \| Download: 1477
22	Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us? 2/25/2021 3:45:30 PM \| Browse: 702 \| Download: 1613
23	Quantitative multiparametric magnetic resonance imaging can aid non-alcoholic steatohepatitis diagnosis in a Japanese cohort 2/20/2021 2:51:13 AM \| Browse: 638 \| Download: 1571
24	Experimental models of metabolic and alcoholic fatty liver disease 12/30/2020 1:59:10 PM \| Browse: 821 \| Download: 1402
25	Validation of genetic variants associated with metabolic dysfunction-associated fatty liver disease in an ethnic-Chinese population 12/18/2020 5:58:43 AM \| Browse: 733 \| Download: 1698
26	Metabolic syndrome and liver disease in the era of bariatric surgery: What you need to know! 10/24/2020 2:27:20 AM \| Browse: 903 \| Download: 1413
27	Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy 9/21/2020 4:02:08 PM \| Browse: 708 \| Download: 1619
28	Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice 9/4/2020 7:25:49 AM \| Browse: 757 \| Download: 2154
29	Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis 8/25/2020 9:16:00 AM \| Browse: 743 \| Download: 1765
30	Lipidomics in non-alcoholic fatty liver disease 8/25/2020 9:16:00 AM \| Browse: 796 \| Download: 1296
31	Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study 7/23/2020 5:00:01 AM \| Browse: 837 \| Download: 1821
32	Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis 7/23/2020 5:00:01 AM \| Browse: 1029 \| Download: 2257
33	Monoacylglycerol lipase reprograms lipid precursors signaling in liver disease 7/7/2020 2:50:53 PM \| Browse: 874 \| Download: 1508
34	Association between non-alcoholic fatty liver disease and obstructive sleep apnea 5/28/2020 1:08:01 PM \| Browse: 924 \| Download: 1561
35	Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease 5/7/2020 5:03:30 AM \| Browse: 1235 \| Download: 1857
36	Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review 4/21/2020 6:56:33 AM \| Browse: 857 \| Download: 1377
37	Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma 1/16/2020 7:58:40 AM \| Browse: 961 \| Download: 1532
38	Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source 9/7/2019 4:43:36 AM \| Browse: 1062 \| Download: 2198
39	Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? 8/14/2019 1:31:33 PM \| Browse: 912 \| Download: 1542
40	Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? 8/7/2019 7:09:17 AM \| Browse: 1054 \| Download: 1848
41	Importance of fatigue and its measurement in chronic liver disease 7/28/2019 10:51:57 AM \| Browse: 1128 \| Download: 1761
42	Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease 7/26/2019 11:08:19 AM \| Browse: 889 \| Download: 1372
43	Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets 7/6/2019 6:23:58 AM \| Browse: 1266 \| Download: 2134
44	Microbial metabolites in non-alcoholic fatty liver disease 5/6/2019 2:06:54 AM \| Browse: 914 \| Download: 1952
45	Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis 4/26/2019 3:40:00 AM \| Browse: 1077 \| Download: 2211
46	Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis 3/7/2019 3:51:24 AM \| Browse: 1299 \| Download: 2155
47	Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects 2/26/2019 11:29:04 AM \| Browse: 1197 \| Download: 1715
48	Current status, problems, and perspectives of non-alcoholic fatty liver disease research 1/14/2019 2:54:12 PM \| Browse: 1359 \| Download: 1812
49	Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology 12/27/2018 9:28:07 AM \| Browse: 943 \| Download: 1484
50	Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 11/21/2018 4:08:59 AM \| Browse: 1006 \| Download: 1306